EWSR1 and Ewing sarcoma: We have shown that gene inactivation of EWSR1–FLI1 using a CRISPR/Cas9 gene editing approach resulted in a highly efficient method to utterly knockout EWSR1–FLI1 in the Ewing sarcoma cell model A673.